Omeros director granted 30,000 stock options
OMEROS CORP (OMER) reported that director Joseph L. Schocken received a grant of 30,000 stock options to purchase common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
OMEROS CORP (OMER) reported that director Joseph L. Schocken received a grant of 30,000 stock options to purchase common stock. The options have an exercise price of $13.71 per share and expire on August 11, 2036. They vest in equal annual installments over three years beginning on the first anniversary of the grant date, and following this grant he holds 30,000 derivative securities directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F1 | 30,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. This option shall vest and become exercisable in equal annual installments over a three-year period beginning on the first anniversary of the date of grant.
Key Figures
Key Terms
Stock Option (Right to Buy) financial
exercise price financial
vesting financial
derivative securities financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did OMER (Omeros Corp) disclose about Joseph L. Schocken in this Form 4?
What is the size of the stock option grant to Joseph L. Schocken at OMER?
What is the exercise price and expiration date of Joseph L. Schocken’s OMER options?
How do Joseph L. Schocken’s OMER stock options vest?
How many OMER derivative securities does Joseph L. Schocken hold after this transaction?
AI-generated analysis. How Rhea-AI works. Not financial advice.